Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations

American Heart Journal

Volumn 156, Issue 4, 2008, Pages 745-750

  Latib, Azeem ^a,b   Cosgrave, John ^c   Godino, Cosmo ^a   Qasim, Asif ^c   Corbett, Simon J ^c   Tavano, Davide ^a   Morici, Nuccia ^a   Cristell, Nicole ^a   Chieffo, Alaide ^a   Carlino, Mauro ^a   Montorfano, Matteo ^a   Airoldi, Flavio ^a,c   Colombo, Antonio ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; AORTA BIFURCATION; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY ANOMALY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; SINGLE DRUG DOSE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 51149096488     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.05.024     Document Type: Article

References (26)

1. Colombo A., Moses J.W., Morice M.C., et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109 (2004) 1244-1249
2. Moussa I., Costa R.A., Leon M.B., et al. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique.". Am J Cardiol 97 (2006) 1317-1321
3. Pan M., Suarez de Lezo J., Medina A., et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J 153 (2007) 15e1-15e7
4. Cutlip D.E., Windecker S., Mehran R., et al. Clinical End Points in Coronary Stent Trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
5. Lansky A.J., Dangas G., Mehran R., et al. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol 39 (2002) 274-280
6. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
7. Popma J., Leon M., and Topol E.J. Atlas of interventional cardiology (1994), Saunders, Philadelphia (Pa)
8. Medina A., Suarez de Lezo J., and Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59 (2006) 183
9. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
10. Morice M.C., Colombo A., Meier B., et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
11. Mehilli J., Dibra A., Kastrati A., et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 27 (2006) 260-266
12. Dibra A., Kastrati A., Mehilli J., et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
13. Ong A.T., Serruys P.W., Aoki J., et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 45 (2005) 1135-1141
14. Cosgrave J., Melzi G., Corbett S., et al. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice. J Am Coll Cardiol 49 (2007) 2320-2328
15. Hoye A., Van Mieghem C.A., Ong A.T., et al. Treatment of de novo bifurcation lesions: comparison of sirolimus- and paclitaxel-eluting stents. Eurointervention 1 (2005) 24-30
16. Pan M., de Lezo J.S., Medina A., et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J 148 (2004) 857-864
17. Steigen T.K., Maeng M., Wiseth R., et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation 114 (2006) 1955-1961
18. Al Suwaidi J., Berger P.B., Rihal C.S., et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 35 (2000) 929-936
19. Ge L., Airoldi F., Iakovou I., et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol 46 (2005) 613-620
20. Hoye A., Iakovou I., Ge L., et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol 47 (2006) 1949-1958
21. Cosgrave J., Melzi G., Biondi-Zoccai G.G., et al. Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol 47 (2006) 2399-2404
22. Colombo A., and Corbett S.J. Drug-eluting stent thrombosis: increasingly recognized but too frequently overemphasized. J Am Coll Cardiol 48 (2006) 203-205
23. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
24. Ong A.T., Hoye A., Aoki J., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953
25. Kuchulakanti P.K., Chu W.W., Torguson R., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
26. Airoldi F., Colombo A., Morici N., et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 116 (2007) 745-754